JAZZ — Jazz Pharmaceuticals PLC

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

About Jazz Pharmaceuticals PLC

Jazz Pharmaceuticals plc identifies, develops, and commercializes pharmaceutical products in the United States, Europe, and internationally. The company offers Xywav to treat cataplexy or excessive daytime sleepiness (EDS) with narcolepsy and idiopathic hypersomnia (IH); Epidiolex for seizures associated with Lennox-Gastaut syndrome (LGS), Dravet syndrome (DS), or tuberous sclerosis complex (TSC); Rylaze for the treatment of acute lymphoblastic l… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$237.56
Market Cap$15.02B
Float60.8M
Shares Outstanding62.7M
P/E (Forward)13.04
P/E (TTM)1,995.00
Price/Sales (TTM)3.38
vs. Analyst Target+5.1% to analyst PT
Profit Margin0.66%
Operating Margin (TTM)23.51%
Revenue (TTM)$4.44B
Earnings Growth (YoY)3.20%
Dividend RateNone
Analyst Target Price$249.67 (18 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 $2.36B $239M $2.21B $1.04B
2021 $3.09B -$329M $2.65B $1.03B
2022 $3.66B -$224M $3.12B $1.47B
2023 $3.83B $415M $3.40B $1.45B
2024 $4.07B $560M $3.62B $1.52B
2025 $4.27B -$356M $3.76B $108M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Jun 2025 $1.05B -$718M
Sep 2025 $1.13B $251M
Dec 2025 $1.20B $203M
Mar 2026 $1.07B $293M

Ownership & Float

Insider Ownership3.0%
Institutional Ownership108.6%
Short Float8.4%
% of All Funds Holding6.52%
Number of Funds Holding536

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$209.84Near-term / short-term trend
Weekly40-Week SMA$169.92Medium-term trend
Weekly80-Week SMA$144.25Cyclical trend (business cycle)
Weekly200-Week SMA$135.39Secular trend (multi-year)
Monthly10-Month SMA$172.79Near-term monthly trend
Monthly20-Month SMA$146.02Medium-term monthly trend
Monthly40-Month SMA$134.84Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$165.00 support 1.03x 2 months ago
$138.00 support 1.44x 5 months ago
$114.00 support 1.02x 8 months ago

Historical Earnings Reactions (76 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 0.38% 0.04% 51.32% 19.94% -8.19%
1 Day -0.33% -0.47% 40.79% 21.37% -14.60%
1 Week -0.04% 0.37% 51.32% 21.37% -15.45%
2 Weeks 1.11% 1.09% 57.89% 35.48% -22.14%
1 Month 2.80% 0.60% 54.67% 49.27% -30.17%

Next earnings: July 24, 2026 (57 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

MonthAvg ReturnWin RateSamples
Jan1.6%57.9%19
Feb0.9%57.9%19
Mar1.6%57.9%19
Apr-0.8%57.9%19
May1.9%44.4%18
Jun16.3%55.6%18
Jul5.6%63.2%19
Aug2.4%52.6%19
Sep-2.0%31.6%19
Oct-2.9%36.8%19
Nov6.6%63.2%19
Dec2.5%52.6%19

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.18% 50.1% 897
Tuesday 0.17% 50.3% 982
Wednesday 0.34% 50.9% 979
Thursday -0.04% 47.3% 960
Friday 0.05% 49.6% 957

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 108.6%

Insider Transactions — Smart Summary

Total insider ownership: 3.0%

12-Month Insider Activity Summary

Total Filings23
Net Value-$9.3M
Net Shares Change-57,161
% of Float-0.1%
C-Suite Filings13
Clusters Detected2

Key Insiders

NameTitleNet ValueFilingsActivity
Patil Neena M EVP and Chief Legal Officer -$4.7M 2 2 sell
COZADD BRUCE C -$4.2M 1 1 sell
Henderson Mary Elizabeth SVP, Technical Operations -$1.7M 3 3 sell
Carr Patricia SVP, Chief Accounting Officer -$1.1M 3 3 sell
RIEDEL NORBERT G -$184,136.8 1 1 sell

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-11-19 – 2025-12-01 7 6 -$10.3M 3 C-suite
2026-03-02 – 2026-03-09 6 5 -$7.5M 4 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2026-03-02 Patil Neena M EVP and Chief Legal Officer -$4.2M Transaction at $159.39, now +49.0%
2026-03-09 Carr Patricia SVP, Chief Accounting Officer -$503,648.803 Transaction at $184.86, now +28.5%
2026-03-02 Henderson Mary Elizabeth SVP, Technical Operations -$1.0M Transaction at $194.49, now +22.1%
2026-03-02 Carr Patricia SVP, Chief Accounting Officer -$456,465.555 Transaction at $192.60, now +23.3%
2026-03-02 RIEDEL NORBERT G -$184,136.8 Transaction at $165.04, now +43.9%
2026-01-21 Patil Neena M EVP and Chief Legal Officer -$560,549 Transaction at $171.16, now +38.8%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Jazz Pharmaceuticals PLC (JAZZ) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for JAZZ on Trend Edge →